Concord Wealth Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15
Closed -$1.17K 927
2024
Q4
$1.17K Hold
15
﹤0.01% 775
2024
Q3
$1.08K Buy
+15
New +$1.06K ﹤0.01% 826

Other funds holding PBH

Concord Wealth Partners's PBH Position: Q1 2025 in Review

Concord Wealth Partners sold out of Prestige Consumer Healthcare (PBH) in Q1 2025, closing a stake of 15 shares — an estimated $1.17K sold.

Concord Wealth Partners first reported a position in PBH in Q3 2024 and held it in 2 quarters. The position peaked at $1.17K in Q4 2024. 359 funds tracked by Wall St. Rank hold PBH as of Q1 2025.

  • Concord Wealth Partners reported no remaining Prestige Consumer Healthcare position as of Q1 2025 after selling out during the quarter.
  • Concord Wealth Partners sold 15 Prestige Consumer Healthcare shares in Q1 2025, an estimated $1.17K.
  • Concord Wealth Partners first reported a position in Prestige Consumer Healthcare in Q3 2024 and held it in 2 quarters.
  • Concord Wealth Partners's Prestige Consumer Healthcare position peaked at $1.17K in Q4 2024.
  • 359 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2025.

Based on Concord Wealth Partners's 13F filing for Q1 2025, filed 2 May 2025.